Skip to content

The predictive value of hearing loss for perioperative neurocognitive impairment in elderly patients undergoing abdominal surgery

The predictive value of hearing loss for perioperative neurocognitive impairment in elderly patients undergoing abdominal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125199
Enrollment
Unknown
Registered
2026-05-22
Start date
2026-05-23
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Neurocognitive Disorders

Interventions

Case series :None

Sponsors

Tianjin Third Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Voluntarily sign informed consent; 2. Elderly patients undergoing elective abdominal surgery under general anesthesia; 3. Age >=65 years old; 4. ASA grade II to III; 5. Body mass index (BMI) 18.5-30 kg/m^2

Exclusion criteria

Exclusion criteria: 1. Patients with previous history of psychosis, brain trauma, dementia, cerebrovascular disease, or other diseases and cognitive impairment; 2. Long-term use of sedatives, hypnotics and anti-psychotic drugs; 3. Patients with severe liver and kidney dysfunction, cardiopulmonary dysfunction, and suspected severe neurocognitive impairment (MMSE score <24); 4. Patients who are unable to complete the hearing test (extremely severe hearing loss or wearing hearing AIDS, unable to cooperate with the test for special reasons); 5. History of allergy to narcotic drugs; Other patients who, in the judgment of their physicians, were not considered to be suitable participants in the study; 6. Alcoholism or drug dependence; 7. Patients with serious diseases of the heart, liver, kidney, respiratory, nervous system and other systems; 8. Severe pain medications fail to relieve patients; 9. Patients deemed by the clinician to be ineligible for participation in the study.

Design outcomes

Primary

MeasureTime frame
The incidence of perioperative neurocognitive dysfunction;

Secondary

MeasureTime frame
Content of phosphorylated Tau 181 and 217;Amyloid ß-40 and ß-42 content;

Countries

China

Contacts

Public ContactHaiyun Wang

Tianjin Third Central Hospital

why819@126.com+86 137 5221 1206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026